Applied Materials Increases Cash Dividend by 25 Percent
SANTA CLARA, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that its Board of Directors has...
Month: March 2024
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
SAINT LAURENT, Quebec, March 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) announces that its wholly-owned...
Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
Late-breaking oral presentation of a subgroup analysis in RAMP 201 Part A heavily pretreated patients receiving avutometinib and defactinib and...
VERSABANK TO PARTICIPATE IN UPCOMING CONFERENCES
LONDON, ON, March 11, 2024 /PRNewswire/ - VersaBank ("VersaBank" or the "Bank") (TSX: VBNK; NASDAQ: VBNK) today announced management will participate...
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON‑080 was reviewed by the study's Data...
NN, Inc. Executive Management to Present at the Sidoti Small-Cap Virtual Investor Conference
CHARLOTTE, N.C., March 11, 2024 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and...
MicroStrategy Completes $800 Million Offering of 0.625% Convertible Senior Notes Due 2030
Contacts MicroStrategy Incorporated Shirish Jajodia Investor Relations ir@microstrategy.com MicroStrategy® Incorporated (Nasdaq: MSTR) (“MicroStrategy”) today announced that, on March 8, 2024,...
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
Webcast to be held Monday, March 18th, 4:30 p.m. ET, register for the webcast here, or at the link provided...
Eltek Ltd. Reports Full year and Fourth Quarter 2023 Financial Results
PETACH TIKVA, Israel, March 11, 2024 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced...
CANOPY GROWTH ANNOUNCES DETAILS REGARDING CONVERTING INTO EXCHANGEABLE SHARES
SMITHS FALLS, ON, March 11, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today...
Acreage Celebrates Launch of Adult-Use Sales at Vernon, Connecticut Dispensary
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF,...
Acreage Celebrates Launch of Adult-Use Sales at Vernon, Connecticut Dispensary
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF,...
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
Long-term extension (LTE) FRONTIER 2 study demonstrated sustained efficacy and similar safety results from Week 16 to Week 52, consistent...
Perion Taps into the World’s Largest DOOH Market, Estimated at $5.2B Through a New Partnership with Way.io, its First Domestic DSP in China
Partnership provides Way.io, which among its partners are Alibaba, Baidu and Tencent, with access to premium Digital Out of Home...
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Commercial launch of INPEFA® (sotagliflozin) continues to progress. with increasing demand across the cardiology community and improving payer accessRead more...
Manhattan Bridge Capital, Inc. Reports Results for 2023
GREAT NECK, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that...
Jack in the Box Inc. Announces Retirement of SVP, Chief Supply Chain Officer Dean Gordon After 15 Years of Dedicated Service
Contacts Chris Brandon Vice President, Investor Relations chris.brandon@jackinthebox.com 619.902.0269 Jack in the Box Inc. (NASDAQ: JACK) announces the retirement of...
Investcorp Europe Acquisition Corp I Amends Business Combination Agreement Following Divestiture of OpSec Security
OpSec Security to be acquired by Crane NXT for $270 million and Zacco to become stand-alone business Investcorp Europe’s Board...
Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
Contacts Investor Contact: Nareg Sagherian Vice President, Head of Global Investor Relations and Corporate Communications Tel: 248-202-9267 Email: ir@evolus.com Media...
Cyngn Reveals First Footage of AI-Powered Autonomous Motrec Tugger
https://vimeo.com/cyngn/motrec-90-seconds?share=copy MENLO PARK, Calif., March 11, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) is excited to share the...
Ceco Environmental to Participate in the 36th Annual Roth Conference on March 18
DALLAS, March 11, 2024 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose...
CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition
SOMERSET, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions...
CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition
SOMERSET, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions...
CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition
SOMERSET, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions...
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Novor V2.0 software with novel ML algorithm trained on HLA peptides yields immunopeptidome from de novo peptide sequencing with further...
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that leading retina specialist Philip...
Akoustis to Attend the 36th Annual Roth Conference on March 17-19, 2024
Charlotte, N.C., March 11, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device...
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month...
Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event
VTX3232 was well-tolerated in the Phase 1 trial with robust target coverage achieved in both plasma and CSF; Ventyx is...
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the submission of a supplemental...
REGENXBIO to Participate in Upcoming Investor Conferences
ROCKVILLE, Md., March 11, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate the following upcoming investor...
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
TARRYTOWN, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food & Drug Administration...
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
U.S. Patent and Trademark Office (USPTO) issues new patent covering Talicia1 as an all-in-one treatment of Helicobacter pylori (H. pylori), supporting...
DreamWorks Animation’s “Kung Fu Panda 4” Becomes Next New Release Movie Motion-Graded in TrueCut Motion, Pixelworks’ Cinematic High-Frame-Rate Format
3D and 2D Premium Format Screens to Showcase the Incredible Cinematic Look of Motion Grading Technology DreamWorks Animation's "Kung Fu...
ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
CAMBRIDGE, Massachusetts and TORONTO, Ontario, March 11, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a biotechnology company focused...
Phoenix to Host Investor Meetings at the 36th Annual Roth Conference March 17-19, 2024
ANAHEIM, CA / ACCESSWIRE / March 11, 2024 / Phoenix Motor Inc. (Nasdaq:PEV) (the "Company" or "Phoenix"), a leading manufacturer...
INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO
Exploratory subgroup analysis from INNOVATE-3 finds that pegylated liposomal doxorubicin (PLD) -naïve patients randomized to receive TTFields therapy and paclitaxel...
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...